Cite
Wilson C, Ray P, Zuccotto F, et al. Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. J Med Chem. 2021;65(1):409-423doi: 10.1021/acs.jmedchem.1c01586.
Wilson, C., Ray, P., Zuccotto, F., Hernandez, J., Aggarwal, A., Mackenzie, C., Caldwell, N., Taylor, M., Huggett, M., Mathieson, M., Murugesan, D., Smith, A., Davis, S., Cocco, M., Parai, M. K., Acharya, A., Tamaki, F., Scullion, P., Epemolu, O., Riley, J., Stojanovski, L., Lopez-Román, E. M., Torres-Gómez, P. A., Toledo, A. M., Guijarro-Lopez, L., Camino, I., Engelhart, C. A., Schnappinger, D., Massoudi, L. M., Lenaerts, A., Robertson, G. T., Walpole, C., Matthews, D., Floyd, D., Sacchettini, J. C., Read, K. D., Encinas, L., Bates, R. H., Green, S. R., & Wyatt, P. G. (2022). Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. Journal of medicinal chemistry, 65(1), 409-423. https://doi.org/10.1021/acs.jmedchem.1c01586
Wilson, Caroline, et al. "Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target." Journal of medicinal chemistry vol. 65,1 (2022): 409-423. doi: https://doi.org/10.1021/acs.jmedchem.1c01586
Wilson C, Ray P, Zuccotto F, Hernandez J, Aggarwal A, Mackenzie C, Caldwell N, Taylor M, Huggett M, Mathieson M, Murugesan D, Smith A, Davis S, Cocco M, Parai MK, Acharya A, Tamaki F, Scullion P, Epemolu O, Riley J, Stojanovski L, Lopez-Román EM, Torres-Gómez PA, Toledo AM, Guijarro-Lopez L, Camino I, Engelhart CA, Schnappinger D, Massoudi LM, Lenaerts A, Robertson GT, Walpole C, Matthews D, Floyd D, Sacchettini JC, Read KD, Encinas L, Bates RH, Green SR, Wyatt PG. Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. J Med Chem. 2022 Jan 13;65(1):409-423. doi: 10.1021/acs.jmedchem.1c01586. Epub 2021 Dec 15. PMID: 34910486.
Copy
Download .nbib